Phase II trial of gefitinib in Chinese female patients with advanced non-small cell lung cancer.
J. Deng
No relevant relationships to disclose
W. J. Fang
No relevant relationships to disclose
X. C. Zhang
No relevant relationships to disclose
J. Chen
No relevant relationships to disclose
J. Qian
No relevant relationships to disclose
H. B. Mou
No relevant relationships to disclose
N. Xu
No relevant relationships to disclose